CoChat

Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo

Open access
Liu, Peng, Wang, Zhipeng, Brown, Sarah, Kannappan, Vinodh, Tawari, Patricia Erebi, Jiang, Wenguo, Irache, Juan M., Tang, James Z., Britland, Stephen, Armesilla, Angel L., Darling, John L., Tang, Xing, Wang, Weiguang · 2014 · Oncotarget
Cited by 123

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

// Peng Liu 1 , Zhipeng Wang 1 , Sarah Brown 1 , Vinodh Kannappan 1 , Patricia Erebi Tawari 1 , Wenguo Jiang 2 , Juan M. Irache 3 , James Z. Tang 1 , Stephen Britland 1 , Angel L. Armesilla 1 , John L. Darling 1 , Xing Tang 4 and Weiguang Wang 1 1 Research Institute in Healthcare Science, Faculty of Science & Engineering, University of Wolverhampton, Wolverhampton, UK 2 Cardiff University-Peking University Cancer Institute, Cardiff University School of Medicine, Henry Wellcome Building, Heath Park, Cardiff, UK 3 School of Pharmacy, University of Navarra, Pamplona, Spain 4 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China Correspondence: Weiguang Wang, email: // Keywords : Breast cancer, cancer stem cells, Disulfiram, NFkappaB, chemoresistance Received : May 11, 2014 Accepted : July 3, 2014 Published : July 4, 2014 Abstract Breast cancer stem cells (BCSCs) are pan-resistant to different anticancer agents and responsible for cancer relapse. Disulfiram (DS), an antialcoholism drug, targets CSCs and reverses pan-chemoresistance. The anticancer application of DS is limited by its very short half-life in the bloodstream. This prompted us to develop a liposome-encapsulated DS (Lipo-DS) and examine its anticancer effect and mechanisms in vitro and in vivo . The relationship between hypoxia and CSCs was examined by in vitro comparison of BC cells cultured in spheroid and hypoxic conditions. To determine the importance of NFκB activation in bridging hypoxia and CSC-related pan-resistance, the CSC characters and drug sensitivity in BC cell lines were observed in NFκB p65 transfected cell lines. The effect of Lipo-DS on the NFκB pathway, CSCs and chemosensitivity was investigated in vitro and in vivo . The spheroid cultured BC cells manifested CSC characteristics and pan-resistance to anticancer drugs. This was related to the hypoxic condition in the spheres. Hypoxia induced activation of NFκB and chemoresistance. Transfection of BC cells with NFκB p65 also induced CSC characters and pan-resistance. Lipo-DS blocked NFκB activation and specifically targeted CSCs in vitro . Lipo-DS also targeted the CSC population in vivo and showed very strong anticancer efficacy. Mice tolerated the treatment very well and no significant in vivo nonspecific toxicity was observed. Hypoxia induced NFκB activation is responsible for stemness and chemoresistance in BCSCs. Lipo-DS targets NFκB pathway and CSCs. Further study may translate DS into cancer therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2166

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Liu, P., Wang, Z., Brown, S., Kannappan, V., Tawari, P. E., Jiang, W., Irache, J. M., Tang, J. Z., Britland, S., Armesilla, A. L., Darling, J. L., Tang, X., & Wang, W.
Venue
Oncotarget
Published
2014-07-04
Volume
5
Issue
17
Pages
7471-7485
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1583812762
Cited by
123
References
5
FWCI
4.02
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.